Holen Sie sich die Stockscreener-App
9.21
9.26%
-0.94
Handel nachbörslich:
9.29
0.08
+0.87%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.15
Offen:
$10.16
24-Stunden-Volumen:
2.92M
Relative Volume:
1.61
Marktkapitalisierung:
$779.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.16M
KGV:
-16.75
EPS:
-0.55
Netto-Cashflow:
$-29.31M
1W Leistung:
-17.99%
1M Leistung:
+0.00%
6M Leistung:
+55.57%
1J Leistung:
+52.23%
1-Tages-Spanne:
$8.97
$10.21
1-Wochen-Bereich:
$8.97
$11.68
52-Wochen-Spanne:
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corporation
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Vergleichen Sie AVXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.21 | 779.55M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9.4%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Down 6.3%Time to Sell? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Up 9.4%Here's Why - MarketBeat
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease - The Manila Times
Anavex's Oral Alzheimer's Drug Shows Breakthrough 36% Disease Slowdown in Phase 3 Trial - StockTitan
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Raised by Barclays PLC - MarketBeat
Barclays PLC Acquires 64,101 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Dru - Asianet Newsable
Anavex Life Sciences: Pioneering Precision Medicine for CNS Disorders - Big News Network
Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from D. Boral Capital - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) vs. Pluri (NASDAQ:PLUR) Critical Comparison - Defense World
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease - Seeking Alpha
Commit To Buy Anavex Life Sciences Corp At $7, Earn 28.6% Using Options - Nasdaq
Jane Street Group LLC Sells 119,531 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Jane Street Group LLC Trims Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 11.3%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading 6.3% HigherStill a Buy? - MarketBeat
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Anavex Life Sciences to Present at JP Morgan Healthcare Conference 2025: Focus on Neurological Breakthroughs - StockTitan
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap UpShould You Buy? - MarketBeat
Anavex Life Sciences Corp. (NASDAQ:AVXL) Short Interest Up 5.7% in December - Defense World
Franklin Resources Inc. Boosts Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Short Interest in Anavex Life Sciences Corp. (NASDAQ:AVXL) Expands By 5.7% - MarketBeat
Geode Capital Management LLC Increases Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Geode Capital Management LLC Increases Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year? - Yahoo Finance
Barclays PLC Boosts Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Barclays PLC - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 7.6%What's Next? - MarketBeat
All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy - Yahoo Finance
HC Wainwright Issues Positive Estimate for AVXL Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of AVXL Q1 Earnings - Defense World
Anavex Life Sciences: Short-Squeeze Target Gains Traction - Investing.com
Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision - Seeking Alpha
Anavex Life Sciences (NASDAQ:AVXL) Price Target Raised to $42.00 at HC Wainwright - Defense World
Anavex Life Sciences (NASDAQ:AVXL) vs. Autolus Therapeutics (NASDAQ:AUTL) Head-To-Head Analysis - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Up 6.9% After Analyst Upgrade - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 6.9% After Analyst Upgrade - MarketBeat
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday - Benzinga
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright highlights blarcamesine’s potential, raises Anavex stock target By Investing.com - Investing.com South Africa
Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability - Yahoo Finance
We're Interested To See How Anavex Life Sciences (NASDAQ:AVXL) Uses Its Cash Hoard To Grow - Simply Wall St
State Street Corp Sells 674,409 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by State Street Corp - MarketBeat
Fmr LLC Decreases Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap Up After Earnings Beat - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap Up After Strong Earnings - MarketBeat
Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday - Benzinga
Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):